ROG:SIXRoche Holding Ltd Dividend Right Cert. Analysis
Data as of 2026-05-18 - not real-time
$137.72
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Rogers Corporation is trading at $137.72, comfortably above its 20‑day SMA ($134.78) and 50‑day SMA ($119.26), and the 200‑day SMA ($96.09), indicating a bullish price trend. Technical signals are mixed – RSI sits at 60 (neutral), while MACD shows a bearish histogram, and volume is on a decreasing trend, suggesting potential short‑term pressure near the 52‑week high of $144.46.
Fundamentally, the company posted a 5.2% revenue increase and a notable EBITDA margin expansion to 16% on $32 million adjusted EBITDA, driven by strong industrial segment growth. However, the DCF fair‑value estimate of roughly $92 places the current price well above intrinsic value, and the firm still reports a negative profit margin and ROE, implying valuation concerns despite the growth narrative.
Fundamentally, the company posted a 5.2% revenue increase and a notable EBITDA margin expansion to 16% on $32 million adjusted EBITDA, driven by strong industrial segment growth. However, the DCF fair‑value estimate of roughly $92 places the current price well above intrinsic value, and the firm still reports a negative profit margin and ROE, implying valuation concerns despite the growth narrative.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram signaling potential pullback
- High 30‑day volatility (~39%) and decreasing volume
- Current price exceeds DCF intrinsic value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Steady revenue growth and improving EBITDA margins
- Negative profit margin and ROE indicating profitability challenges
- Valuation gap between market price and fair value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Secular demand from EV, aerospace, and renewable‑energy markets
- Strong cash position and low debt enhancing financial flexibility
- Potential for margin expansion as industrial segment gains share
Key Metrics & Analysis
Financial Health
Revenue Growth5.20%
Profit Margin-6.81%
P/E Ratio31.5
ROE-4.54%
ROA2.68%
Debt/Equity2.50
P/B Ratio2.1
Op. Cash Flow$95.3M
Free Cash Flow$89.4M
Industry P/E38.0
Technical Analysis
TrendBullish
RSI60.2
Support$120.69
Resistance$144.46
MA 20$134.78
MA 50$119.26
MA 200$96.09
MACDBearish
VolumeDecreasing
Fear & Greed Index88.8
Valuation
Fair Value$91.90
Target Price$150.00
Upside/Downside8.92%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.25
Volatility39.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.